v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (49,422,895) $ (30,996,623)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 11,879,167 7,946,529
Issuance of common stock for services 107,510
Issuance of common stock warrant 68,597
Amortization of in-process research and development 4,014,062
Amortization of operating lease right-of-use asset 65,655 152,212
Amortization of deferred financing costs 179,492
Deferred income tax expense (benefit) (74,317) 792,720
Changes in operating assets and liabilities:    
Accounts receivable, net of allowances (686,235)
Inventory (339,252) (8,940,201)
Prepaid expenses (1,616,170) 1,386,824
Accounts payable (5,655,793) 5,166,831
Accrued expenses 19,961,209 8,506,648
Accrued compensation (1,421,127) 1,481,023
Operating lease liability (46,316) (167,911)
Net Cash Used In Operating Activities (22,986,413) (14,671,948)
Cash Flows From Investing Activities:    
License fee payments (7,000,000)
Net Cash Used in Investing Activities (7,000,000)
Cash Flows From Financing Activities:    
Proceeds from (repayment of) note payable and advance from employee (1,000,000) 1,300,000
Repayment of advance from employee   (300,000)
Net proceeds from loan agreement 9,635,000
Proceeds from exercise of warrants 9,731,103
Deferred Financing Costs (892,551)
Proceeds from sale of Series A preferred stock 100
Redemption of Series A preferred stock (100)
Net proceeds from common stock offerings 25,268,094 16,509,194
Net Cash Provided By Financing Activities 42,741,646 17,509,194
Net Change in Cash and Cash Equivalents 12,755,233 2,837,246
Cash and Cash Equivalents - Beginning of Period 4,252,290 3,251,880
Cash and Cash Equivalents - End of Period 17,007,523 6,089,126
Supplemental Disclosures of Cash Flow Information and Non-cash Transactions:    
Interest paid 303,644
Operating lease right-of-use asset and liability recorded 786,697
Warrants issued for loan agreement included in deferred financing costs 749,280
Deferred financing costs included in accrued expenses $ 1,762,500